✦ LIBER ✦

Carboxy-Substituted Cinnamides: A Novel Series of Potent, Orally Active LTB4 Receptor Antagonists

✍ Scribed by Greenspan, Paul D.; Fujimoto, Roger A.; Marshall, Paul J.; Raychaudhuri, Anil; Lipson, Kenneth E.; Zhou, Huanghai; Doti, Robert A.; Coppa, David E.; Zhu, Lijuan; Pelletier, Roberta

Book ID: 111874054
Publisher: American Chemical Society
Year: 1999
Tongue: English
Weight: 182 KB
Volume: 42
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm980540v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Carboxy-Substituted

ChemInform Abstract: Carboxy-Substituted Cinnamides: A Novel Series of Potent, Orally Active LTB4 Receptor Antagonists.

✍ Paul D. Greenspan; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

Discovery of Novel, Potent, and Orally A

Discovery of Novel, Potent, and Orally Active Spiro-Urea Human Glucagon Receptor Antagonists.

✍ Dong-Ming Shen; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

ChemInform Abstract: N-Aryl Cinnamides:

ChemInform Abstract: N-Aryl Cinnamides: A Novel Class of Rigid and Highly Potent Leukotriene B4 Receptor Antagonists.

✍ P. D. GREENSPAN; A. J. MAIN; S. S. BHAGWAT; L. I. BARSKY; R. A. DOTI; A. R. ENGL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Discovery of Potent Orally Active Thromb

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

✍ Chackalamannil, Samuel; Xia, Yan; Greenlee, William J.; Clasby, Martin; Doller, 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 88 KB

Discovery of novel, potent, selective, a

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

✍ Dong-Ming Shen; Edward J. Brady; Mari R. Candelore; Qing Dallas-Yang; Victor D.- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 461 KB

A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzyme

ChemInform Abstract: N-3-Substituted Pyr

ChemInform Abstract: N-3-Substituted Pyrimidinones as Potent, Orally Active, AT1 Selective Angiotensin II Receptor Antagonists.

✍ A. SALIMBENI; R. CANEVOTTI; F. PALEARI; D. POMA; S. CALIARI; F. FICI; R. CIRILLO 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB